ICARES Medicus, Inc. (TPEX:6612)

Taiwan · Delayed Price · Currency is TWD

70.10

+0.10 (0.14%)

Sep 8, 2026, 1:30 PM CST

Market Cap	3.64B -27.0%
Revenue (ttm)	1.21B +12.0%
Net Income	93.56M -0.7%
EPS	1.79 -1.2%
Shares Out	51.91M
PE Ratio	39.15
Forward PE	n/a
Dividend	0.27 (0.38%)
Ex-Dividend Date	Aug 26, 2026

Volume	27,431
Open	70.30
Previous Close	70.00
Day's Range	69.30 - 70.50
52-Week Range	59.96 - 100.38
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services. In addition, it offers artificial crystal products; and l... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2011

Employees 77

Stock Exchange Taipei Exchange

Ticker Symbol 6612

Full Company Profile

Financial Performance

In 2025, ICARES Medicus's revenue was 1.13 billion, an increase of 31.54% compared to the previous year's 859.79 million. Earnings were 51.23 million, a decrease of -50.32%.

Financial Statements